

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.27500644 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.27500644 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.03494787 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.03494787 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.51367301 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.19522884 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.84571114 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.84571114 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.84571114 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 5.76211921 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.75548259 |
| 12 | bile acid biosynthetic process (GO:0006699) | 5.71341128 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.63886100 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.50121194 |
| 15 | regulation of fibrinolysis (GO:0051917) | 5.48124644 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.46994343 |
| 17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.41948718 |
| 18 | protein carboxylation (GO:0018214) | 5.41948718 |
| 19 | urea metabolic process (GO:0019627) | 5.41464869 |
| 20 | urea cycle (GO:0000050) | 5.41464869 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.41197739 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.32606113 |
| 23 | cysteine metabolic process (GO:0006534) | 5.28257674 |
| 24 | regulation of protein activation cascade (GO:2000257) | 5.20884429 |
| 25 | complement activation, alternative pathway (GO:0006957) | 5.15672193 |
| 26 | epoxygenase P450 pathway (GO:0019373) | 5.14863558 |
| 27 | nitrogen cycle metabolic process (GO:0071941) | 4.98421993 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 4.92532057 |
| 29 | regulation of complement activation (GO:0030449) | 4.89147064 |
| 30 | bile acid metabolic process (GO:0008206) | 4.83848884 |
| 31 | reverse cholesterol transport (GO:0043691) | 4.79901604 |
| 32 | homocysteine metabolic process (GO:0050667) | 4.78563043 |
| 33 | regulation of cholesterol esterification (GO:0010872) | 4.72529398 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 4.71306815 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 4.68281448 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.66451839 |
| 37 | plasma lipoprotein particle remodeling (GO:0034369) | 4.66127786 |
| 38 | protein-lipid complex remodeling (GO:0034368) | 4.66127786 |
| 39 | macromolecular complex remodeling (GO:0034367) | 4.66127786 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.58397137 |
| 41 | lysine catabolic process (GO:0006554) | 4.57598969 |
| 42 | lysine metabolic process (GO:0006553) | 4.57598969 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.48698689 |
| 44 | alpha-amino acid catabolic process (GO:1901606) | 4.48403295 |
| 45 | triglyceride homeostasis (GO:0070328) | 4.47137189 |
| 46 | acylglycerol homeostasis (GO:0055090) | 4.47137189 |
| 47 | glycine metabolic process (GO:0006544) | 4.42473843 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.41565829 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.41565829 |
| 50 | phospholipid efflux (GO:0033700) | 4.36111365 |
| 51 | plasma lipoprotein particle clearance (GO:0034381) | 4.34139755 |
| 52 | cellular glucuronidation (GO:0052695) | 4.32014799 |
| 53 | exogenous drug catabolic process (GO:0042738) | 4.31145326 |
| 54 | coenzyme catabolic process (GO:0009109) | 4.27865100 |
| 55 | cellular ketone body metabolic process (GO:0046950) | 4.22028319 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 4.20771775 |
| 57 | serine family amino acid metabolic process (GO:0009069) | 4.18403835 |
| 58 | fibrinolysis (GO:0042730) | 4.17604736 |
| 59 | bile acid and bile salt transport (GO:0015721) | 4.15781923 |
| 60 | glutamate metabolic process (GO:0006536) | 4.15164021 |
| 61 | omega-hydroxylase P450 pathway (GO:0097267) | 4.15020449 |
| 62 | cellular amino acid catabolic process (GO:0009063) | 4.14333458 |
| 63 | imidazole-containing compound metabolic process (GO:0052803) | 4.10733743 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 4.10709812 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 4.10094764 |
| 66 | amine catabolic process (GO:0009310) | 4.10094764 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.08883037 |
| 68 | ethanol oxidation (GO:0006069) | 4.02427313 |
| 69 | negative regulation of hemostasis (GO:1900047) | 4.01886626 |
| 70 | negative regulation of blood coagulation (GO:0030195) | 4.01886626 |
| 71 | cholesterol efflux (GO:0033344) | 4.01673424 |
| 72 | drug metabolic process (GO:0017144) | 3.94642910 |
| 73 | plasma lipoprotein particle assembly (GO:0034377) | 3.93906431 |
| 74 | low-density lipoprotein particle remodeling (GO:0034374) | 3.93745390 |
| 75 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.90724230 |
| 76 | arginine metabolic process (GO:0006525) | 3.90340180 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 3.89571733 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.84749314 |
| 79 | acute-phase response (GO:0006953) | 3.83342713 |
| 80 | glucuronate metabolic process (GO:0019585) | 3.82883863 |
| 81 | uronic acid metabolic process (GO:0006063) | 3.82883863 |
| 82 | negative regulation of coagulation (GO:0050819) | 3.80724625 |
| 83 | regulation of plasminogen activation (GO:0010755) | 3.79065877 |
| 84 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.73800239 |
| 85 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.73357897 |
| 86 | positive regulation of lipid catabolic process (GO:0050996) | 3.71902485 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 3.69832740 |
| 88 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68755909 |
| 89 | cofactor catabolic process (GO:0051187) | 3.68211876 |
| 90 | ethanol metabolic process (GO:0006067) | 3.65603269 |
| 91 | ketone body metabolic process (GO:1902224) | 3.63994892 |
| 92 | intestinal cholesterol absorption (GO:0030299) | 3.63866901 |
| 93 | negative regulation of wound healing (GO:0061045) | 3.63800089 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.63743400 |
| 95 | negative regulation of lipase activity (GO:0060192) | 3.63130709 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.62093198 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.61707959 |
| 98 | organic acid catabolic process (GO:0016054) | 3.61707959 |
| 99 | complement activation, classical pathway (GO:0006958) | 3.60543342 |
| 100 | protein-lipid complex assembly (GO:0065005) | 3.60303183 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.60151903 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.60151903 |
| 103 | protein activation cascade (GO:0072376) | 3.59583434 |
| 104 | complement activation (GO:0006956) | 3.59379800 |
| 105 | sterol homeostasis (GO:0055092) | 3.58495517 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.57905339 |
| 107 | regulation of bile acid biosynthetic process (GO:0070857) | 3.57286989 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.56523035 |
| 109 | short-chain fatty acid metabolic process (GO:0046459) | 3.55470034 |
| 110 | acetyl-CoA metabolic process (GO:0006084) | 3.53131367 |
| 111 | cytolysis (GO:0019835) | 3.51450382 |
| 112 | intestinal absorption (GO:0050892) | 3.49771368 |
| 113 | drug catabolic process (GO:0042737) | 3.48487616 |
| 114 | basement membrane organization (GO:0071711) | 3.45454788 |
| 115 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.43353616 |
| 116 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.38569862 |
| 117 | positive regulation of extracellular matrix organization (GO:1903055) | 3.37630089 |
| 118 | negative regulation of complement activation (GO:0045916) | 3.27773766 |
| 119 | protein-lipid complex subunit organization (GO:0071825) | 3.26989150 |
| 120 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.23125894 |
| 121 | positive regulation of hemostasis (GO:1900048) | 3.17759279 |
| 122 | positive regulation of blood coagulation (GO:0030194) | 3.17759279 |
| 123 | proline metabolic process (GO:0006560) | 3.16871881 |
| 124 | regulation of apoptotic cell clearance (GO:2000425) | 3.15632133 |
| 125 | hormone catabolic process (GO:0042447) | 3.15113622 |
| 126 | lipoprotein metabolic process (GO:0042157) | 3.09732395 |
| 127 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.06998552 |
| 128 | regulation of humoral immune response (GO:0002920) | 3.02972400 |
| 129 | adhesion of symbiont to host (GO:0044406) | 3.02238428 |
| 130 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.97737808 |
| 131 | positive regulation of coagulation (GO:0050820) | 2.95875001 |
| 132 | acute inflammatory response (GO:0002526) | 2.94032903 |
| 133 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.92995871 |
| 134 | diacylglycerol metabolic process (GO:0046339) | 2.92209558 |
| 135 | flavonoid metabolic process (GO:0009812) | 2.85887790 |
| 136 | opsonization (GO:0008228) | 2.84418087 |
| 137 | low-density lipoprotein particle clearance (GO:0034383) | 2.84280538 |
| 138 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.82340881 |
| 139 | phenylpropanoid metabolic process (GO:0009698) | 2.81652154 |
| 140 | protein heterotrimerization (GO:0070208) | 2.79325205 |
| 141 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.76906692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.20315675 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.04843848 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.51091900 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.33491570 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.21323406 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.91859882 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.85949450 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.94977144 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.70452093 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.39432741 |
| 11 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.31764554 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.22954899 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05716439 |
| 14 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00560831 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7535570 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.88804390 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70740486 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.64957818 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60322707 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.55297187 |
| 21 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53535332 |
| 22 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.44538885 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37806209 |
| 24 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36087839 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.34437533 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34083462 |
| 27 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.33901834 |
| 28 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33660962 |
| 29 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.32508262 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.27911998 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.25823327 |
| 32 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25247475 |
| 33 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.22043690 |
| 34 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21163763 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.20666276 |
| 36 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18766418 |
| 37 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16517759 |
| 38 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.15117069 |
| 39 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13869469 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13222187 |
| 41 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10764414 |
| 42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.10543599 |
| 43 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.10457517 |
| 44 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09239092 |
| 45 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.07846825 |
| 46 | P68_20966046_ChIP-Seq_HELA_Human | 1.07007620 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.06640655 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06561196 |
| 49 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06301894 |
| 50 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.03456049 |
| 51 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02334547 |
| 52 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.01888089 |
| 53 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.00086035 |
| 54 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.99202147 |
| 55 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98925974 |
| 56 | * ZNF263_19887448_ChIP-Seq_K562_Human | 0.98849324 |
| 57 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.98118188 |
| 58 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96334250 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94844209 |
| 60 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94229762 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94034024 |
| 62 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93984928 |
| 63 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93562939 |
| 64 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93562939 |
| 65 | SA1_27219007_Chip-Seq_Bcells_Human | 0.92697689 |
| 66 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92100595 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91952597 |
| 68 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.91865946 |
| 69 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.91597633 |
| 70 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91546563 |
| 71 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.91040754 |
| 72 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.90635195 |
| 73 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89991141 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87881181 |
| 75 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87852151 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87248843 |
| 77 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86901661 |
| 78 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84931669 |
| 79 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.84381858 |
| 80 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83312324 |
| 81 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.79998153 |
| 82 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78013411 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.75990135 |
| 84 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74071942 |
| 85 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.73917039 |
| 86 | * AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.72638471 |
| 87 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66946282 |
| 88 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.66782481 |
| 89 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.65846163 |
| 90 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.64145693 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.63737307 |
| 92 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.63290799 |
| 93 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.63058417 |
| 94 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.62413577 |
| 95 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61283634 |
| 96 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.60455706 |
| 97 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60048609 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59336851 |
| 99 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59093091 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.59024350 |
| 101 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.58654639 |
| 102 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.57812950 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.56630585 |
| 104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.55762633 |
| 105 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.55750680 |
| 106 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.55150688 |
| 107 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.53148714 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.52513835 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.52422554 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.50214668 |
| 111 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.49124037 |
| 112 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.48695072 |
| 113 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.48315531 |
| 114 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.47570322 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47549103 |
| 116 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.47023681 |
| 117 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.46459347 |
| 118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.46190240 |
| 119 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.46084440 |
| 120 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45963496 |
| 121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.45852051 |
| 122 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44652519 |
| 123 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.44074013 |
| 124 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.44074013 |
| 125 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.43863753 |
| 126 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.43795341 |
| 127 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43435687 |
| 128 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.42859343 |
| 129 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.41579991 |
| 130 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41577193 |
| 131 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.41393919 |
| 132 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.41070658 |
| 133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.40320182 |
| 134 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.40165780 |
| 135 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.39902843 |
| 136 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.39897148 |
| 137 | CJUN_26792858_Chip-Seq_BT549_Human | 0.39610951 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39609397 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39545270 |
| 140 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.38852972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.10825320 |
| 2 | MP0005360_urolithiasis | 7.26994345 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.00805632 |
| 4 | MP0005365_abnormal_bile_salt | 5.78338397 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.64459649 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.98732932 |
| 7 | MP0003252_abnormal_bile_duct | 3.84015838 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.37981885 |
| 9 | MP0009840_abnormal_foam_cell | 3.30980368 |
| 10 | MP0005083_abnormal_biliary_tract | 2.90420490 |
| 11 | MP0003195_calcinosis | 2.84422403 |
| 12 | MP0005332_abnormal_amino_acid | 2.70112333 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.40065485 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.10019799 |
| 15 | MP0003705_abnormal_hypodermis_morpholog | 2.08682388 |
| 16 | MP0000609_abnormal_liver_physiology | 2.07562645 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 1.97984608 |
| 18 | MP0005058_abnormal_lysosome_morphology | 1.96895361 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 1.95085140 |
| 20 | MP0005257_abnormal_intraocular_pressure | 1.91603669 |
| 21 | MP0003868_abnormal_feces_composition | 1.86218847 |
| 22 | MP0004858_abnormal_nervous_system | 1.83384530 |
| 23 | MP0002138_abnormal_hepatobiliary_system | 1.79076536 |
| 24 | MP0001958_emphysema | 1.76320617 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.75751777 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.73970491 |
| 27 | MP0009697_abnormal_copulation | 1.55325889 |
| 28 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.44438167 |
| 29 | MP0003011_delayed_dark_adaptation | 1.42072710 |
| 30 | MP0001764_abnormal_homeostasis | 1.38608136 |
| 31 | MP0006054_spinal_hemorrhage | 1.35581720 |
| 32 | MP0003656_abnormal_erythrocyte_physiolo | 1.33174979 |
| 33 | MP0003566_abnormal_cell_adhesion | 1.31080924 |
| 34 | MP0010368_abnormal_lymphatic_system | 1.28640811 |
| 35 | MP0003186_abnormal_redox_activity | 1.28404286 |
| 36 | MP0005451_abnormal_body_composition | 1.21876377 |
| 37 | MP0000598_abnormal_liver_morphology | 1.18742050 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.17769083 |
| 39 | MP0009053_abnormal_anal_canal | 1.09434327 |
| 40 | MP0003172_abnormal_lysosome_physiology | 1.07689381 |
| 41 | MP0002254_reproductive_system_inflammat | 1.06771402 |
| 42 | MP0005508_abnormal_skeleton_morphology | 1.06317379 |
| 43 | MP0009384_cardiac_valve_regurgitation | 1.03791610 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.02521084 |
| 45 | MP0005647_abnormal_sex_gland | 1.00503908 |
| 46 | MP0002249_abnormal_larynx_morphology | 0.97668194 |
| 47 | MP0009764_decreased_sensitivity_to | 0.97082218 |
| 48 | MP0009763_increased_sensitivity_to | 0.96695263 |
| 49 | MP0000003_abnormal_adipose_tissue | 0.95941744 |
| 50 | MP0002933_joint_inflammation | 0.95596543 |
| 51 | MP0000604_amyloidosis | 0.93338519 |
| 52 | MP0000751_myopathy | 0.89680849 |
| 53 | MP0005670_abnormal_white_adipose | 0.88860987 |
| 54 | MP0005375_adipose_tissue_phenotype | 0.87115272 |
| 55 | MP0000013_abnormal_adipose_tissue | 0.85696652 |
| 56 | MP0005220_abnormal_exocrine_pancreas | 0.85492524 |
| 57 | MP0000858_altered_metastatic_potential | 0.84084471 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 0.82876942 |
| 59 | MP0005084_abnormal_gallbladder_morpholo | 0.82112752 |
| 60 | MP0001533_abnormal_skeleton_physiology | 0.81915728 |
| 61 | MP0002998_abnormal_bone_remodeling | 0.81791245 |
| 62 | MP0000678_abnormal_parathyroid_gland | 0.80268217 |
| 63 | MP0005275_abnormal_skin_tensile | 0.80095187 |
| 64 | MP0002971_abnormal_brown_adipose | 0.79298033 |
| 65 | MP0008469_abnormal_protein_level | 0.79128195 |
| 66 | MP0009642_abnormal_blood_homeostasis | 0.78961760 |
| 67 | MP0001849_ear_inflammation | 0.78400735 |
| 68 | MP0010030_abnormal_orbit_morphology | 0.77537262 |
| 69 | MP0005390_skeleton_phenotype | 0.77095107 |
| 70 | MP0005408_hypopigmentation | 0.75114875 |
| 71 | MP0005409_darkened_coat_color | 0.73807555 |
| 72 | MP0003091_abnormal_cell_migration | 0.73661267 |
| 73 | MP0005376_homeostasis/metabolism_phenot | 0.72389469 |
| 74 | MP0003950_abnormal_plasma_membrane | 0.71637205 |
| 75 | MP0002060_abnormal_skin_morphology | 0.71593888 |
| 76 | MP0009780_abnormal_chondrocyte_physiolo | 0.70539472 |
| 77 | MP0001243_abnormal_dermal_layer | 0.69046454 |
| 78 | MP0005334_abnormal_fat_pad | 0.68975882 |
| 79 | MP0003279_aneurysm | 0.68241226 |
| 80 | MP0005503_abnormal_tendon_morphology | 0.68179042 |
| 81 | MP0002078_abnormal_glucose_homeostasis | 0.68006686 |
| 82 | MP0004130_abnormal_muscle_cell | 0.66727723 |
| 83 | MP0002108_abnormal_muscle_morphology | 0.66311833 |
| 84 | MP0002132_abnormal_respiratory_system | 0.63910739 |
| 85 | MP0005023_abnormal_wound_healing | 0.63712136 |
| 86 | MP0005165_increased_susceptibility_to | 0.63468896 |
| 87 | MP0001661_extended_life_span | 0.62947088 |
| 88 | MP0000681_abnormal_thyroid_gland | 0.62694321 |
| 89 | MP0004782_abnormal_surfactant_physiolog | 0.62004992 |
| 90 | MP0003183_abnormal_peptide_metabolism | 0.61454968 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.61293661 |
| 92 | MP0000566_synostosis | 0.60743752 |
| 93 | MP0003879_abnormal_hair_cell | 0.60611474 |
| 94 | MP0000163_abnormal_cartilage_morphology | 0.60485081 |
| 95 | MP0006036_abnormal_mitochondrial_physio | 0.60350787 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.58697098 |
| 97 | MP0009765_abnormal_xenobiotic_induced | 0.58372374 |
| 98 | MP0001756_abnormal_urination | 0.55171214 |
| 99 | MP0003690_abnormal_glial_cell | 0.53930583 |
| 100 | MP0003329_amyloid_beta_deposits | 0.53925566 |
| 101 | MP0001542_abnormal_bone_strength | 0.53486966 |
| 102 | MP0003724_increased_susceptibility_to | 0.52451583 |
| 103 | MP0002295_abnormal_pulmonary_circulatio | 0.52423570 |
| 104 | MP0009379_abnormal_foot_pigmentation | 0.51732231 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.50921266 |
| 106 | MP0005266_abnormal_metabolism | 0.50871611 |
| 107 | MP0005395_other_phenotype | 0.50460186 |
| 108 | MP0005595_abnormal_vascular_smooth | 0.47036226 |
| 109 | MP0005448_abnormal_energy_balance | 0.46353880 |
| 110 | MP0009672_abnormal_birth_weight | 0.45790212 |
| 111 | MP0004272_abnormal_basement_membrane | 0.45675014 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.44870297 |
| 113 | MP0002168_other_aberrant_phenotype | 0.44309386 |
| 114 | MP0005535_abnormal_body_temperature | 0.44150961 |
| 115 | MP0009115_abnormal_fat_cell | 0.43551896 |
| 116 | MP0002928_abnormal_bile_duct | 0.43129017 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.42767694 |
| 118 | MP0000249_abnormal_blood_vessel | 0.42738710 |
| 119 | MP0005164_abnormal_response_to | 0.42331973 |
| 120 | MP0003436_decreased_susceptibility_to | 0.42110333 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.41242867 |
| 122 | MP0005464_abnormal_platelet_physiology | 0.40057657 |
| 123 | MP0003075_altered_response_to | 0.39211520 |
| 124 | MP0008873_increased_physiological_sensi | 0.38812771 |
| 125 | MP0002970_abnormal_white_adipose | 0.37158186 |
| 126 | MP0004883_abnormal_blood_vessel | 0.37134674 |
| 127 | MP0002796_impaired_skin_barrier | 0.36623695 |
| 128 | MP0002282_abnormal_trachea_morphology | 0.36553694 |
| 129 | MP0002837_dystrophic_cardiac_calcinosis | 0.36241980 |
| 130 | MP0000579_abnormal_nail_morphology | 0.34094350 |
| 131 | MP0002896_abnormal_bone_mineralization | 0.33714554 |
| 132 | MP0001915_intracranial_hemorrhage | 0.33660856 |
| 133 | MP0005166_decreased_susceptibility_to | 0.33284750 |
| 134 | MP0000767_abnormal_smooth_muscle | 0.33211566 |
| 135 | MP0001853_heart_inflammation | 0.32676191 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.28635169 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.05194384 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.96592416 |
| 4 | Xanthomatosis (HP:0000991) | 6.42139308 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.37116839 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.11997381 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.95299483 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.32073749 |
| 9 | Complement deficiency (HP:0004431) | 5.14491174 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.76278101 |
| 11 | Hypoalphalipoproteinemia (HP:0003233) | 4.45283926 |
| 12 | Joint hemorrhage (HP:0005261) | 4.42524756 |
| 13 | Hyperammonemia (HP:0001987) | 4.39369948 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.29729683 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.28336614 |
| 16 | Epidermoid cyst (HP:0200040) | 4.20283214 |
| 17 | Hyperglycinemia (HP:0002154) | 4.19859942 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17243144 |
| 19 | Ketosis (HP:0001946) | 4.10467736 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 4.04881726 |
| 21 | Abnormality of complement system (HP:0005339) | 4.04829458 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.04449944 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91342567 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.82705032 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.82705032 |
| 26 | Fat malabsorption (HP:0002630) | 3.82543782 |
| 27 | Hyperglycinuria (HP:0003108) | 3.77477132 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.76566880 |
| 29 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71972721 |
| 30 | Vertebral compression fractures (HP:0002953) | 3.60361852 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.50171968 |
| 32 | Myocardial infarction (HP:0001658) | 3.41942617 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.38446937 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.23117224 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.19762566 |
| 36 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.18990480 |
| 37 | Hyperbilirubinemia (HP:0002904) | 3.13438839 |
| 38 | Cervical subluxation (HP:0003308) | 3.04586848 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 2.98397239 |
| 40 | Delayed CNS myelination (HP:0002188) | 2.98146490 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.92983729 |
| 42 | Ketoacidosis (HP:0001993) | 2.91941233 |
| 43 | Skin nodule (HP:0200036) | 2.87344683 |
| 44 | Steatorrhea (HP:0002570) | 2.84627972 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81783981 |
| 46 | Spontaneous abortion (HP:0005268) | 2.70395173 |
| 47 | Aortic dissection (HP:0002647) | 2.68419595 |
| 48 | Aortic aneurysm (HP:0004942) | 2.68291620 |
| 49 | Vascular calcification (HP:0004934) | 2.66605265 |
| 50 | Ankle contracture (HP:0006466) | 2.65208202 |
| 51 | Vascular tortuosity (HP:0004948) | 2.63306679 |
| 52 | Mitral stenosis (HP:0001718) | 2.61242319 |
| 53 | Nephritis (HP:0000123) | 2.59995120 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.56670563 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.53266655 |
| 56 | Abnormality of carpal bone ossification (HP:0006257) | 2.51273986 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.51157876 |
| 58 | Blue sclerae (HP:0000592) | 2.51009661 |
| 59 | Metabolic acidosis (HP:0001942) | 2.49975362 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.47589988 |
| 61 | Hypochromic microcytic anemia (HP:0004840) | 2.47050732 |
| 62 | Protrusio acetabuli (HP:0003179) | 2.46546010 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.46444333 |
| 64 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46444333 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.44181440 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.44181440 |
| 67 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.42070024 |
| 68 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.42070024 |
| 69 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.42070024 |
| 70 | Abnormal gallbladder morphology (HP:0012437) | 2.36239438 |
| 71 | Lethargy (HP:0001254) | 2.36211961 |
| 72 | Hypoglycemic seizures (HP:0002173) | 2.35063102 |
| 73 | Neonatal short-limb short stature (HP:0008921) | 2.34807887 |
| 74 | Spastic diplegia (HP:0001264) | 2.33384166 |
| 75 | Abnormal delivery (HP:0001787) | 2.31687983 |
| 76 | Cholelithiasis (HP:0001081) | 2.30732928 |
| 77 | Follicular hyperkeratosis (HP:0007502) | 2.29878316 |
| 78 | Wormian bones (HP:0002645) | 2.29866231 |
| 79 | Abnormality of the acetabulum (HP:0003170) | 2.29388158 |
| 80 | Amyloidosis (HP:0011034) | 2.27488924 |
| 81 | Acanthocytosis (HP:0001927) | 2.26888644 |
| 82 | Peritonitis (HP:0002586) | 2.26339726 |
| 83 | Arterial tortuosity (HP:0005116) | 2.24417367 |
| 84 | Soft skin (HP:0000977) | 2.22846478 |
| 85 | Achilles tendon contracture (HP:0001771) | 2.22586265 |
| 86 | Premature rupture of membranes (HP:0001788) | 2.21958027 |
| 87 | Coxa vara (HP:0002812) | 2.21904804 |
| 88 | Purpura (HP:0000979) | 2.21770801 |
| 89 | Glomerulonephritis (HP:0000099) | 2.21577118 |
| 90 | Broad metatarsal (HP:0001783) | 2.21062503 |
| 91 | Abnormal cartilage morphology (HP:0002763) | 2.20840328 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.20391153 |
| 93 | Late onset (HP:0003584) | 2.20092233 |
| 94 | Neonatal onset (HP:0003623) | 2.19902166 |
| 95 | Abnormal gallbladder physiology (HP:0012438) | 2.19158459 |
| 96 | Cholecystitis (HP:0001082) | 2.19158459 |
| 97 | Fragile skin (HP:0001030) | 2.18455315 |
| 98 | Malnutrition (HP:0004395) | 2.17711514 |
| 99 | Menorrhagia (HP:0000132) | 2.17188745 |
| 100 | Spinal rigidity (HP:0003306) | 2.16910751 |
| 101 | Hydroxyprolinuria (HP:0003080) | 2.15925617 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 2.15925617 |
| 103 | Joint stiffness (HP:0001387) | 2.15059915 |
| 104 | Gout (HP:0001997) | 2.15021359 |
| 105 | Polycythemia (HP:0001901) | 2.14906113 |
| 106 | Bladder diverticulum (HP:0000015) | 2.13293641 |
| 107 | Abnormality of the Achilles tendon (HP:0005109) | 2.13244013 |
| 108 | Enlarged kidneys (HP:0000105) | 2.11902321 |
| 109 | Irritability (HP:0000737) | 2.09681341 |
| 110 | Shallow orbits (HP:0000586) | 2.08802976 |
| 111 | Esophageal varix (HP:0002040) | 2.08328667 |
| 112 | Cerebral edema (HP:0002181) | 2.07622992 |
| 113 | Flat acetabular roof (HP:0003180) | 2.05906081 |
| 114 | Gingival bleeding (HP:0000225) | 2.04327631 |
| 115 | Pancreatitis (HP:0001733) | 2.02928079 |
| 116 | Back pain (HP:0003418) | 2.02888450 |
| 117 | Ulnar bowing (HP:0003031) | 2.02340312 |
| 118 | Aneurysm (HP:0002617) | 2.02265138 |
| 119 | Nonimmune hydrops fetalis (HP:0001790) | 2.01661519 |
| 120 | Opisthotonus (HP:0002179) | 2.01063101 |
| 121 | Sensorimotor neuropathy (HP:0007141) | 1.99084333 |
| 122 | Abnormal ossification of hand bones (HP:0005921) | 1.97419320 |
| 123 | Hypophosphatemic rickets (HP:0004912) | 1.95138894 |
| 124 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95128124 |
| 125 | Abnormality of the gallbladder (HP:0005264) | 1.92657089 |
| 126 | Thrombophlebitis (HP:0004418) | 1.92452058 |
| 127 | Distal upper limb amyotrophy (HP:0007149) | 1.92317451 |
| 128 | Upper limb amyotrophy (HP:0009129) | 1.92317451 |
| 129 | Abnormality of iron homeostasis (HP:0011031) | 1.92059194 |
| 130 | Abnormality of dentin (HP:0010299) | 1.91037025 |
| 131 | Hemorrhage of the eye (HP:0011885) | 1.90778842 |
| 132 | Type 1 muscle fiber predominance (HP:0003803) | 1.89357235 |
| 133 | Hypertriglyceridemia (HP:0002155) | 1.88988941 |
| 134 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88827594 |
| 135 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.88237395 |
| 136 | Brushfield spots (HP:0001088) | 1.87858898 |
| 137 | Vomiting (HP:0002013) | 1.87703533 |
| 138 | J-shaped sella turcica (HP:0002680) | 1.87698510 |
| 139 | Rickets (HP:0002748) | 1.86433962 |
| 140 | Increased connective tissue (HP:0009025) | 1.85816913 |
| 141 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85790632 |
| 142 | Ovoid vertebral bodies (HP:0003300) | 1.85680176 |
| 143 | Biconcave vertebral bodies (HP:0004586) | 1.84029917 |
| 144 | Elbow flexion contracture (HP:0002987) | 1.83262103 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.82849492 |
| 146 | Hyperglycemia (HP:0003074) | 1.82253701 |
| 147 | Atrophic scars (HP:0001075) | 1.82157985 |
| 148 | Poikilocytosis (HP:0004447) | 1.82018290 |
| 149 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.81185901 |
| 150 | Ectopia lentis (HP:0001083) | 1.79447669 |
| 151 | Dilatation of the ascending aorta (HP:0005111) | 1.79269956 |
| 152 | Slender build (HP:0001533) | 1.78478702 |
| 153 | Wrist flexion contracture (HP:0001239) | 1.77260637 |
| 154 | Abnormal hand bone ossification (HP:0010660) | 1.76138081 |
| 155 | Thin bony cortex (HP:0002753) | 1.72906776 |
| 156 | Abnormal tarsal ossification (HP:0008369) | 1.71729662 |
| 157 | Ileus (HP:0002595) | 1.70814139 |
| 158 | Stridor (HP:0010307) | 1.70785340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.40010497 |
| 2 | ERN1 | 4.79942298 |
| 3 | SIK1 | 4.52512379 |
| 4 | TRIB3 | 3.80819418 |
| 5 | FGFR4 | 3.77251979 |
| 6 | PKN2 | 3.27954033 |
| 7 | ERBB4 | 2.42823128 |
| 8 | EPHA2 | 2.36584888 |
| 9 | MYLK | 2.22188359 |
| 10 | LMTK2 | 2.15571189 |
| 11 | TAOK3 | 2.13808851 |
| 12 | INSRR | 2.13557206 |
| 13 | FLT3 | 2.13160682 |
| 14 | LATS1 | 2.11337322 |
| 15 | NEK9 | 2.10059778 |
| 16 | MST1R | 1.92661164 |
| 17 | PTK6 | 1.75365677 |
| 18 | MAPK11 | 1.69215164 |
| 19 | PRPF4B | 1.65199658 |
| 20 | PIK3CG | 1.63373801 |
| 21 | ABL2 | 1.55173489 |
| 22 | PAK4 | 1.47458502 |
| 23 | MAP2K4 | 1.46356724 |
| 24 | PRKD2 | 1.37154860 |
| 25 | CDC42BPA | 1.33889674 |
| 26 | MAP3K10 | 1.32203388 |
| 27 | AKT3 | 1.32136300 |
| 28 | KDR | 1.30899868 |
| 29 | NTRK1 | 1.30445563 |
| 30 | PDGFRA | 1.30282361 |
| 31 | DDR2 | 1.26768929 |
| 32 | STK38L | 1.25058073 |
| 33 | MET | 1.24394148 |
| 34 | TYK2 | 1.20685770 |
| 35 | PIM2 | 1.20624124 |
| 36 | LATS2 | 1.20476056 |
| 37 | TESK1 | 1.18120839 |
| 38 | MAP3K3 | 1.17002744 |
| 39 | SMG1 | 1.12916645 |
| 40 | FRK | 1.12264001 |
| 41 | MAP2K3 | 1.11662550 |
| 42 | TBK1 | 1.10600937 |
| 43 | EEF2K | 1.10158955 |
| 44 | MAP3K6 | 1.04376312 |
| 45 | PRKAA2 | 1.02588288 |
| 46 | PTK2 | 1.01957609 |
| 47 | ZAP70 | 1.00981997 |
| 48 | ERBB2 | 0.99930160 |
| 49 | EPHB1 | 0.96485111 |
| 50 | BMX | 0.96097675 |
| 51 | DYRK1B | 0.95822243 |
| 52 | CDK6 | 0.94053650 |
| 53 | MAPK4 | 0.91703347 |
| 54 | PDGFRB | 0.91084563 |
| 55 | MAPKAPK3 | 0.90696196 |
| 56 | MAP3K7 | 0.89729701 |
| 57 | JAK2 | 0.89654683 |
| 58 | MAP3K11 | 0.88880595 |
| 59 | FGFR2 | 0.88036831 |
| 60 | ARAF | 0.87548870 |
| 61 | EPHA3 | 0.87114522 |
| 62 | EPHB2 | 0.85751615 |
| 63 | MOS | 0.84097674 |
| 64 | NME2 | 0.83592705 |
| 65 | STK38 | 0.82606411 |
| 66 | CSK | 0.82321830 |
| 67 | RIPK1 | 0.80056372 |
| 68 | KIT | 0.79279591 |
| 69 | TGFBR2 | 0.74822263 |
| 70 | JAK1 | 0.72558312 |
| 71 | MAPK12 | 0.71900186 |
| 72 | FER | 0.71707493 |
| 73 | ILK | 0.71453570 |
| 74 | TTN | 0.70396914 |
| 75 | WNK4 | 0.69716454 |
| 76 | JAK3 | 0.67742641 |
| 77 | MAP3K1 | 0.66186170 |
| 78 | PRKD3 | 0.64771018 |
| 79 | GRK6 | 0.63775280 |
| 80 | GRK5 | 0.62553341 |
| 81 | DAPK2 | 0.61708257 |
| 82 | TAOK2 | 0.61252615 |
| 83 | CAMK1D | 0.60642005 |
| 84 | PRKCZ | 0.60592651 |
| 85 | RPS6KA2 | 0.59502933 |
| 86 | LIMK1 | 0.59468830 |
| 87 | GSK3A | 0.59015419 |
| 88 | TESK2 | 0.58130848 |
| 89 | EIF2AK1 | 0.57544155 |
| 90 | PAK2 | 0.57461818 |
| 91 | MAP3K2 | 0.55798690 |
| 92 | IRAK3 | 0.55798086 |
| 93 | MTOR | 0.55095838 |
| 94 | PRKACG | 0.54711140 |
| 95 | TIE1 | 0.54581944 |
| 96 | MAP3K13 | 0.53288829 |
| 97 | STK3 | 0.53127126 |
| 98 | RET | 0.51796375 |
| 99 | RPS6KC1 | 0.51507595 |
| 100 | RPS6KL1 | 0.51507595 |
| 101 | MAP2K1 | 0.51409228 |
| 102 | PDK1 | 0.50484811 |
| 103 | KSR2 | 0.48399614 |
| 104 | ADRBK1 | 0.46389023 |
| 105 | CAMK2G | 0.45053829 |
| 106 | SRC | 0.43496294 |
| 107 | PDPK1 | 0.42839709 |
| 108 | PINK1 | 0.42183154 |
| 109 | MAPK15 | 0.42051108 |
| 110 | IGF1R | 0.41805745 |
| 111 | CDK8 | 0.41779421 |
| 112 | MAPK7 | 0.41734983 |
| 113 | CDK4 | 0.41465340 |
| 114 | MAP3K5 | 0.41349675 |
| 115 | PRKAA1 | 0.41143258 |
| 116 | LRRK2 | 0.40871129 |
| 117 | PDK2 | 0.40408321 |
| 118 | PTK2B | 0.38613048 |
| 119 | RPS6KA6 | 0.37638623 |
| 120 | FGFR3 | 0.37197874 |
| 121 | DAPK3 | 0.37094044 |
| 122 | PIK3CA | 0.36998245 |
| 123 | MAP3K14 | 0.36138314 |
| 124 | FGFR1 | 0.36032321 |
| 125 | ROCK1 | 0.35730843 |
| 126 | IRAK2 | 0.34754347 |
| 127 | PAK3 | 0.33947091 |
| 128 | RPS6KA4 | 0.33446855 |
| 129 | PBK | 0.33265589 |
| 130 | ICK | 0.33107277 |
| 131 | TRPM7 | 0.32538139 |
| 132 | PRKG2 | 0.31381384 |
| 133 | EGFR | 0.30955308 |
| 134 | TLK1 | 0.30197154 |
| 135 | CSF1R | 0.29021446 |
| 136 | MAP2K2 | 0.28531553 |
| 137 | ABL1 | 0.26790372 |
| 138 | PRKD1 | 0.24989970 |
| 139 | MAP3K8 | 0.24176723 |
| 140 | PRKCQ | 0.22276631 |
| 141 | SGK3 | 0.21710683 |
| 142 | MAP2K6 | 0.20670450 |
| 143 | INSR | 0.19075788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45660987 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.67334459 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.36359969 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.27285875 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.03672433 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78823938 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65208785 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64705079 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.64006298 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58865757 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57217243 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39081214 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.27787667 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05900670 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.04627961 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04564924 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.92788907 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90866714 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.88785008 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.88014850 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86502331 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85262659 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81709549 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.69733900 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.69590285 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67441001 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64435083 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.64107385 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.63916821 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62975190 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62825011 |
| 32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.56512682 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54115065 |
| 34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.54040844 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.51941271 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50094095 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.46122494 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44827551 |
| 39 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38767967 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34547935 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33456048 |
| 42 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.29982349 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27287992 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.24836075 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24186217 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22225868 |
| 47 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17831849 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15859090 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14720884 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.06863871 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.06569322 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.04934200 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04446522 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.96863539 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.92537510 |
| 56 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.92224169 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.90701856 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.86722939 |
| 59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.84425347 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82621952 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82478498 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 0.81273182 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.74015906 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73184931 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70112005 |
| 66 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63004064 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60970430 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59393828 |
| 69 | Focal adhesion_Homo sapiens_hsa04510 | 0.55478692 |
| 70 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49486448 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44117233 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.42705315 |
| 73 | Lysosome_Homo sapiens_hsa04142 | 0.39511282 |
| 74 | Prion diseases_Homo sapiens_hsa05020 | 0.36900770 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35379996 |
| 76 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33978872 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33706320 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27535743 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.26920672 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.25701240 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22676123 |
| 82 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18955277 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17704641 |
| 84 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.17620443 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.15376896 |
| 86 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.14646401 |
| 87 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.14431489 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.13025249 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09205585 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.07854411 |
| 91 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06129850 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.04628965 |
| 93 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.02887692 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.02321532 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.00211585 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2122431 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1852611 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | -0.1793145 |
| 99 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1547091 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1314838 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | -0.1285155 |
| 102 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1263302 |
| 103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1251620 |
| 104 | Malaria_Homo sapiens_hsa05144 | -0.0883224 |
| 105 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0701125 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0679368 |
| 107 | Amoebiasis_Homo sapiens_hsa05146 | -0.0679023 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0646087 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0445370 |
| 110 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0415192 |
| 111 | ECM-receptor interaction_Homo sapiens_hsa04512 | -0.0281418 |
| 112 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0201848 |

